Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide in Complex Regional Pain Syndrome
NCT00067743Phase 2Completed
- Sponsor
- Celgene Corporation
- Start
- Aug 2003
- Primary completion
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in complex regional pain syndrome type I (CRPS), sponsored by Celgene Corporation. Started Aug 2003; status: completed.
02
Drugs
lenalidomide
03
Conditions
complex regional pain syndrome type I (CRPS)
Beyond the preview
Go deeper on NCT00067743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00067743.